IMPLANTATION OF A CARDIAC CONTRACTILITY MODULATOR IN CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: RESULTS OF A 6-MONTH FOLLOW-UP OF ONE HUNDRED PATIENTS

被引：1

作者：

Uskach, T. M. ^{[1
,2
]}

Sapelnikov, O., V ^{[1
]}

Safiullina, A. A. ^{[1
]}

Grishin, I. R. ^{[1
]}

Amanatova, V. A. ^{[1
]}

Akchurin, R. S. ^{[1
]}

Tereshchenko, S. N. ^{[1
,2
]}

机构：

[1] Natl Med Res Ctr Cardiol, Moscow, Russia

[2] Russian Med Acad Continuous Profess Educ, Moscow, Russia

来源：

VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV | 2021年 / 23卷 / 01期

关键词：

heart failure; atrial fibrillation; modulation of heart contractility; left ventricular ejection; fraction; quality of life;

D O I：

10.15825/1995-1191-2021-1-30-37

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

Aim: to study the effect of cardiac contractility modulation (CCM) in patients with chronic heart failure (CHF) and atrial fibrillation (AF). Materials and methods. In a group of 100 patients with CHF and AF, the following studies were performed before implantation of the CCM and after 6 months of follow-up: 12-channel ECG, transthoracic Echocardiography, 6-minute walk test, determination of the level of pro-natriuretic N-terminal peptide (NT-proBNP), and a questionnaire based on the Minnesota quality of life questionnaire for patients with CHF (MHFLQ). All patients received long-term optimal medication therapy for CHF before surgery. Results. The results show a positive effect of the use of MCC in patients with CHF and AF on reverse LV remodeling, functional class of CHF, and levels of NT-pro-BNP regardless of the form of AF. Conclusion. The use of MCC may be a promising treatment method in addition to optimal medication therapy in patients with CHF and AF.

引用

页码：30 / 37

页数：8

共 21 条

[1] Cardiac contractility modulation: a novel approach for the treatment of heart failure [J].

Abi-Samra, Freddy ;

Gutterman, David .

HEART FAILURE REVIEWS, 2016, 21 (06) :645-660

[2] Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction [J].

Anker, Stefan D. ;

Borggrefe, Martin ;

Neuser, Hans ;

Ohlow, Marc-Alexander ;

Roeger, Susanne ;

Goette, Andreas ;

Remppis, Bjoern A. ;

Kuck, Karl-Heinz ;

Najarian, Kevin B. ;

Gutterman, David D. ;

Rousso, Benny ;

Burkhoff, Daniel ;

Hasenfuss, Gerd .

EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (09) :1103-1113

[3] A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS [J].

Brignole, Michele ;

Pokushalov, Evgeny ;

Pentimalli, Francesco ;

Palmisano, Pietro ;

Chieffo, Enrico ;

Occhetta, Eraldo ;

Quartieri, Fabio ;

Calo, Leonardo ;

Ungar, Andrea ;

Mont, Lluis ;

Menozzi, Carlo ;

Alboni, Paolo ;

Bertero, Giovanni ;

Klersy, Catherine ;

Noventa, Franco ;

Brignole, M. ;

Oddone, D. ;

Donateo, O. ;

Maggi, R. ;

Croci, F. ;

Solano, A. ;

Pentimalli, F. ;

Palmisano, P. ;

Landolina, M. ;

Chieffo, E. ;

Taravelli, E. ;

Occhetta, E. ;

Quartieri, F. ;

Bottoni, N. ;

Iori, M. ;

Calo, L. ;

Sgueglia, M. ;

Pieragnoli ;

Giorni, A. ;

Nesti, M. ;

Giannini, I. ;

Ungar, A. ;

Padeletti, L. ;

Pokushalov, E. ;

Romanov, A. ;

Peregudov, I. ;

Vidorreda, S. ;

Nunez, R. ;

Mont, L. .

EUROPEAN HEART JOURNAL, 2018, 39 (45) :3999-4008

[4] The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].

Cleland, JGF ;

Swedberg, K ;

Follath, F ;

Komajda, M ;

Cohen-Solal, A ;

Aguilar, JC ;

Dietz, R ;

Gavazzi, A ;

Hobbs, R ;

Korewicki, J ;

Madeira, HC ;

Moiseyev, VS ;

Preda, I ;

van Gilst, WH ;

Widimsky, J ;

Freemantle, N ;

Eastaugh, J ;

Mason, J .

EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463

[5] Atrial fibrillation and congestive heart failure: Specific considerations at the intersection of two common and important cardiac disease sets [J].

Ehrlich, JR ;

Nattel, S ;

Hohnloser, SH .

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (04) :399-405

[6]

Hindricks G, 2021, EUR HEART J, V42, P546, DOI [10.1093/eurheartj/ehaa945, 10.1093/eurheartj/ehaa612]

[7]

Huang Weijian, 2018, Card Electrophysiol Clin, V10, P519, DOI 10.1016/j.ccep.2018.05.016

[8] Pulmonary-vein isolation for atrial fibrillation in patients with heart failure [J].

Khan, Mohammed N. ;

Jais, Pierre ;

Cummings, Jennifer ;

Di Biase, Luigi ;

Sanders, Prashanthan ;

Martin, David O. ;

Kautzner, Josef ;

Hao, Steven ;

Themistoclakis, Sakis ;

Fanelli, Raffaele ;

Potenza, Domenico ;

Massaro, Raimondo ;

Wazni, Oussama ;

Schweikert, Robert ;

Saliba, Walid ;

Wang, Paul ;

Al-Ahmad, Amin ;

Beheiry, Salwa ;

Santarelli, Pietro ;

Starling, Randall C. ;

Dello Russo, Antonio ;

Pelargonio, Gemma ;

Brachmann, Johannes ;

Schibgilla, Volker ;

Bonso, Aldo ;

Casella, Michela ;

Raviele, Antonio ;

Haissaguerre, Michel ;

Natale, Andrea .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1778-1785

[9] Atrial Fibrillation in Heart Failure [J].

Lardizabal, Joel A. ;

Deedwania, Prakash C. .

MEDICAL CLINICS OF NORTH AMERICA, 2012, 96 (05) :987-+

[10] Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials [J].

Mando, Ramy ;

Goel, Akshay ;

Habash, Fuad ;

Saad, Marwan ;

Ayoub, Karam ;

Vallurupalli, Srikanth ;

Maskoun, Waddah .

CARDIOVASCULAR THERAPEUTICS, 2019, 2019

← 1 2 3 →